Evaluating the Role of p38 MAPK in the Accelerated Cell Senescence of Werner Syndrome Fibroblasts
Progeroid syndromes show features of accelerated ageing and are used as models for human ageing, of which Werner syndrome (WS) is one of the most widely studied. WS fibroblasts show accelerated senescence that may result from p38 MAP kinase activation since it is prevented by the p38 inhibitor SB203...
Main Authors: | Terence Davis, Amy J. C. Brook, Michal J. Rokicki, Mark C. Bagley, David Kipling |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-04-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/9/2/23 |
Similar Items
-
Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome
by: Mark C. Bagley, et al.
Published: (2010-06-01) -
Synthesis and p38 Inhibitory Activity of Some Novel Substituted N,N′-Diarylurea Derivatives
by: Dianxi Zhu, et al.
Published: (2016-05-01) -
Blocking p38 Signaling Reduces the Activation of Pro-inflammatory Cytokines and the Phosphorylation of p38 in the Habenula and Reverses Depressive-Like Behaviors Induced by Neuroinflammation
by: Ya-wei Zhao, et al.
Published: (2018-05-01) -
Changes in Oxidative Phosphorylation Activity in Fibroblasts at p38 MAPK Pathway Inhibition
by: Irina A Shurygina, et al.
Published: (2019-12-01) -
P38 MAPK Pharmacological Inhibitor SB203580 Alleviates Total Parenteral Nutrition-Induced Loss of Intestinal Barrier Function but Promotes Hepatocyte Lipoapoptosis
by: Yong-Tao Xiao, et al.
Published: (2017-02-01)